- By ICR Secretariat
- Posted Thursday, August 31, 2023
NICE gives green light for MSD's Keytruda
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
MSD has revealed that the National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda.